News & Announcements

Biotome’s Epitope Mapping Pipeline Discovers Unique Diagnostic Targets for SARS-CoV-2

This study employed peptide microarray technology (Carmona 2015) to identify highly specific linear B-cell epitopes of the SARS-CoV-2 Spike protein that can distinguish between SARS-CoV-2 infection and pre-existing immunity to seasonal coronaviruses.

Technical Briefs

Oct 17